Stratos Wealth Advisors LLC Purchases 28,022 Shares of Tilray Inc (NASDAQ:TLRY)

Stratos Wealth Advisors LLC raised its position in shares of Tilray Inc (NASDAQ:TLRY) by 253.5% in the third quarter, HoldingsChannel reports. The firm owned 39,074 shares of the company’s stock after buying an additional 28,022 shares during the quarter. Stratos Wealth Advisors LLC’s holdings in Tilray were worth $69,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Madrona Financial Services LLC purchased a new position in shares of Tilray in the first quarter worth approximately $124,000. SpiderRock Advisors LLC bought a new position in Tilray in the first quarter worth approximately $247,000. Private Advisor Group LLC boosted its stake in shares of Tilray by 7.3% during the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company’s stock worth $434,000 after acquiring an additional 12,021 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after acquiring an additional 213,834 shares during the period. Finally, Capstone Investment Advisors LLC increased its stake in shares of Tilray by 320.9% in the 1st quarter. Capstone Investment Advisors LLC now owns 95,736 shares of the company’s stock worth $236,000 after purchasing an additional 72,989 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Roth Mkm cut their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.

Tilray Stock Performance

TLRY opened at $1.68 on Thursday. The company has a 50 day simple moving average of $1.72 and a two-hundred day simple moving average of $1.80. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The firm has a market cap of $1.52 billion, a P/E ratio of -6.22 and a beta of 2.13. Tilray Inc has a 1-year low of $1.45 and a 1-year high of $2.97.

Tilray (NASDAQ:TLRY) last issued its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04). The company had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. Tilray’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.10) EPS. Equities analysts forecast that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.